SB6183 requires health insurers to cover all Food and Drug Administration-approved HIV antiviral drugs without prior authorization, step therapy, or any other utilization management protocols in health plans.
The Washington State House of Representatives passed SB6183 on March 3, 2026 by a vote of 93 to 1. We have assigned pluses to the nays because decisions about insurance coverage should be made via voluntary agreements between providers and consumers, not dictated by the state. Affordable healthcare coverage is best achieved through free-market competition and price transparency rather than government interference by removing cost-control mechanisms in favor of certain pharmaceuticals.
